Anavex Life Sciences (AVXL) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | 28.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.82% |
| Sep 30, 2025 | 16.03% |
| Sep 30, 2024 | 5.87% |
| Mar 31, 2017 | -10.06% |
| Dec 31, 2016 | -100.00% |
| Sep 30, 2016 | -21.64% |
| Jun 30, 2016 | -81.71% |
| Dec 31, 2015 | -128.94% |
| Sep 30, 2015 | -175.89% |
| Jun 30, 2015 | -11.20% |
| Mar 31, 2015 | -58.74% |
| Dec 31, 2014 | 9.14% |
| Sep 30, 2014 | -169.62% |
| Jun 30, 2014 | 20.63% |
| Mar 31, 2014 | 27.89% |
| Dec 31, 2013 | 50.00% |
| Sep 30, 2013 | 8.37% |